VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection-Reference-Cited by-同舟云学术

VAD with or without subsequent high-dose melphalan followed by autologous stem cell support in AL amyloidosis: Japanese experience and criteria for patient selection

Published:2004-01 Issue:4 Volume:11 Page:245-256
ISSN:1350-6129
Container-title:Amyloid
language:en
Short-container-title:Amyloid

Author:

Gono Takahisa,Matsuda Masayuki,Shimojima Yasuhiro,Ishii Wataru,Koyama Jun,Sakashita Kazuo,Koike Kenichi,Hoshii Yoshinobu,Ikeda Shu-ichi

Publisher

Informa UK Limited

Subject

Internal Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/13506120412331336907

Reference20 articles.

1. Dose-Intensive Melphalan With Blood Stem-Cell Support for the Treatment of AL (Amyloid Light-Chain) Amyloidosis: Survival and Responses in 25 Patients

2. Eligibility for Hematopoietic Stem-Cell Transplantation for Primary Systemic Amyloidosis Is a Favorable Prognostic Factor for Survival

3. Useful polyclonal antibodies against synthetic peptides corresponding to immunoglobulin light chain constant region for immunohistochemical detection of immunoglobulin light chain amyloidosis

4. Phenotypic analysis of plasma cells in bone marrow using flow cytometry in AL amyloidosis

Cited by 35 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Digital whole‐slide imaging of changes in amyloid after peripheral blood stem cell transplantation in patients with amyloid light‐chain amyloidosis;Pathology International;2024-07-17

2. Targeted treatments of AL and ATTR amyloidosis;Heart Failure Reviews;2021-11-16

3. Bortezomib–dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study;International Journal of Hematology;2016-11-10

4. Immunoglobulin Light Chain Systemic Amyloidosis;Plasma Cell Dyscrasias;2016

5. Treatment of Immunoglobulin Light Chain Amyloidosis;Mayo Clinic Proceedings;2015-08